To determine the biological function of FXR in breast cancer cells, we employed the FXR antagonist Z-GS and observed its cytotoxic and inhibitory effects on MCF-10A, MDA-MB-231, and MCF-7 cells. This evidence concerns the gene NR1H4 and breast carcinoma.